{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:56:47Z","timestamp":1778821007018,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ekir.2024.04.044","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:52:45Z","timestamp":1713977565000},"page":"2286-2289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic Features of Kidney Disease in Patients With Cystic Fibrosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Tiffany N.","family":"Caza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.04.044_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","article-title":"Risk factors for chronic kidney disease in adults with cystic fibrosis","volume":"184","author":"Quon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ekir.2024.04.044_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0344-0338(84)80108-9","article-title":"Renal biopsies in cystic fibrosis","volume":"178","author":"Michalsen","year":"1984","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.ekir.2024.04.044_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2215\/CJN.00750209","article-title":"Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance","volume":"4","author":"Yahiaoui","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.04.044_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.04.044_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.04.044_bib6","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/adc.66.12.1444","article-title":"Severe nephropathy in three adolescents with cystic fibrosis","volume":"66","author":"Melzi","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ekir.2024.04.044_bib7","first-page":"413","article-title":"Secondary amyloidosis and cystic fibrosis. A morphological and histochemical study of five cases","volume":"2","author":"Bontempini","year":"1987","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.ekir.2024.04.044_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ajcp\/85.4.419","article-title":"Secondary (AA) amyloidosis in cystic fibrosis. A report of three cases","volume":"85","author":"Travis","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ekir.2024.04.044_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ckj\/sft146","article-title":"Renal amyloidosis in cystic fibrosis: role of colchicine therapy","volume":"7","author":"Santoro","year":"2014","journal-title":"Clin Kidney J"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924016796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924016796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T09:11:50Z","timestamp":1719997910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924016796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2468024924016796"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.04.044","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic Features of Kidney Disease in Patients With Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}